SHANGHAI BIO-HEART BIOLOGICAL TECHNOLOGY CO., LTD. Shanghai Bio-heart Biological Technology Co., Ltd.
Equities
2185
CNE100004JH3
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.9 HKD | -3.55% |
|
-15.18% | -44.44% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Shanghai Bio-Heart Biological Technology Co Ltd is a China-based company mainly engaged in interventional instruments. The Company's main businesses are the development and production of interventional cardiovascular devices. The Company's main products include fully bioresorbable scaffolds (BRS) and renal denervation (RDN). The Company's products are mainly used to meet medical needs for the treatment of coronary, peripheral artery disease and hypertension.
Calendar
2024-08-01
- Q2 2024 Earnings Release (Projected)
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.9
Average target price
-
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -44.44% | 61.23M | |
| +8.77% | 125B | |
| -10.82% | 10.51B | |
| -5.04% | 8.65B | |
| +21.59% | 4.77B | |
| +7.47% | 3.42B | |
| -0.74% | 3.03B | |
| -13.27% | 1.97B | |
| -12.45% | 1.95B | |
| -30.28% | 1.62B |
- Stock Market
- Equities
- 2185 Stock
- News Shanghai Bio-heart Biological Technology Co., Ltd.
- Chairman to Boost Shanghai Bio-heart Stake
